Finance

Lists
603939:SHA
Yifeng Pharmacy Chain Co Ltd
CNÂ¥22.47
+1.77%
(+0.39) 1D
Sep 28, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603939...
Open
CNÂ¥22.00
High
CNÂ¥22.48
Low
CNÂ¥21.99
Mkt. cap
26.77B
Avg. vol.
8.43M
Volume
6.42M
Dividend
3.12%
Quarterly dividend
CNÂ¥0.18
Ex-dividend date
Jun 25, 2026
P/E ratio
15.67
52-wk high
CNÂ¥25.80
52-wk low
CNÂ¥17.68
EPS
CNÂ¥1.43
Shares outstanding
376.81M
No. of employees
39K
Open
CNÂ¥22.00
High
CNÂ¥22.48
Low
CNÂ¥21.99
Mkt. cap
26.77B
Avg. vol.
8.43M
Volume
6.42M
Dividend
3.12%
Quarterly dividend
CNÂ¥0.18
Ex-dividend date
Jun 25, 2026
P/E ratio
15.67
52-wk high
CNÂ¥25.80
52-wk low
CNÂ¥17.68
EPS
CNÂ¥1.43
Shares outstanding
376.81M
No. of employees
39K
About Yifeng Pharmacy Chain Co Ltd
CEO-
Employees39K
Founded2001
Headquarters-
SectorDrug
Websiteyfdyf.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.56B
7.15B
6.09B
6.04B
Cost of goods sold
3.28B
4.61B
3.65B
3.64B
Cost of revenue
3.28B
4.61B
3.65B
3.64B
Research and development expenses
6.52M
6.40M
5.85M
5.70M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.71B
1.92B
1.68B
1.69B
Operating expense
1.71B
1.96B
1.70B
1.72B
Total operating expenses
4.98B
6.58B
5.35B
5.36B
Operating income
581.35M
569.56M
737.22M
683.93M
Other non operating income
-21.22M
11.29M
-3.60M
-4.68M
EBT including unusual items
506.37M
686.44M
723.64M
718.13M
EBT excluding unusual items
562.73M
582.35M
737.00M
682.84M
Income tax expense
130.99M
176.58M
177.55M
195.15M
Effective tax rate
25.87%
25.72%
24.54%
27.17%
Other operating expenses
-5.94M
39.09M
12.78M
21.42M
Net income
344.51M
453.93M
499.55M
464.23M
Net profit margin
6.19%
6.35%
8.21%
7.68%
Earnings per share
0.27
-
-
-
Interest and investment income
44.17M
25.65M
35.23M
37.61M
Interest expense
-41.56M
-24.16M
-31.85M
-34.02M
Net interest expenses
2.61M
1.50M
3.39M
3.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
643.69M
634.91M
802.56M
740.94M
Gain or loss from assets sale
33.87M
-65.46M
-
-23.21M
AI content may include mistakes. Learn more
Google apps